Oramed Pharmaceuticals (Israel) Today
| ORMP Stock | 8.60 0.02 0.23% |
Performance17 of 100
| Odds Of DistressLess than 50
|
Oramed Pharmaceuticals is trading at 8.60 as of the 23rd of April 2024, a -0.23 percent decrease since the beginning of the trading day. The stock's open price was 8.62. Oramed Pharmaceuticals has 50 percent odds of going through some form of financial distress in the next two years but had a very solid returns during the last 90 days. Equity ratings for Oramed Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of March 2024 and ending today, the 23rd of April 2024. Click here to learn more.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York. The company has 17.38 M outstanding shares. More on Oramed Pharmaceuticals
Moving against Oramed Stock
| 0.53 | ORA | Ormat Technologies | PairCorr |
| 0.43 | FVT | Ai Conversation Systems | PairCorr |
Follow Valuation Daily Balance Of Power
Check how we calculate scores
Oramed Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Oramed Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Oramed Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO, Director | Nadav Kidron |
Oramed Pharmaceuticals (ORMP) is traded on Tel Aviv Stock Exchange in Israel and employs 10 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 189.3 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Oramed Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Oramed Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Oramed Pharmaceuticals has 17.38 M outstanding shares.
Oramed Pharmaceuticals has accumulated about 26.19 M in cash with (14.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.51.
Check Oramed Pharmaceuticals Probability Of Bankruptcy
Oramed Stock Price Odds Analysis
What are Oramed Pharmaceuticals' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Oramed Pharmaceuticals jumping above the current price in 90 days from now is about 85.32%. The Oramed Pharmaceuticals probability density function shows the probability of Oramed Pharmaceuticals stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon the stock has a beta coefficient of 95.0. This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Oramed Pharmaceuticals will likely underperform. In addition to that, oramed Pharmaceuticals has an alpha of 492.9098, implying that it can generate a 492.91 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Oramed Pharmaceuticals to move above the current price in 90 days from now is about 85.32 (This Oramed Pharmaceuticals probability density function shows the probability of Oramed Stock to fall within a particular range of prices over 90 days) .
Oramed Pharmaceuticals Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Oramed Pharmaceuticals market risk premium is the additional return an investor will receive from holding Oramed Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Oramed Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Oramed Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Oramed Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 963.9 | |||
| Standard Deviation | 2335.14 | |||
| Variance | 5452867.78 | |||
| Downside Variance | 830.71 |
Oramed Stock Against Markets
Picking the right benchmark for Oramed Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Oramed Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Oramed Pharmaceuticals is critical whether you are bullish or bearish towards Oramed Pharmaceuticals at a given time. Please also check how Oramed Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Oramed Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Oramed Pharmaceuticals Corporate Directors
Oramed Pharmaceuticals corporate directors refer to members of an Oramed Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Oramed Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Oramed Pharmaceuticals' board members must vote for the resolution. The Oramed Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Miriam Kidron | Chief Scientific Officer, Director | Profile | |
| Xiaopeng Li | Independent Director | Profile | |
| Leonard Sank | Independent Director | Profile | |
| Xiaoming Gao | Director | Profile |
How to buy Oramed Stock?
Before investing in Oramed Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Oramed Pharmaceuticals. To buy Oramed Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Oramed Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Oramed Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Oramed Pharmaceuticals stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Oramed Pharmaceuticals stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Oramed Pharmaceuticals, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Oramed Stock please use our How to Invest in Oramed Pharmaceuticals guide.
Already Invested in Oramed Pharmaceuticals?
The danger of trading Oramed Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Oramed Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Oramed Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Oramed Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Oramed Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Oramed Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Oramed Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Oramed Pharmaceuticals Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oramed Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Oramed Stock refer to our How to Trade Oramed Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Oramed Stock analysis
When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |